The Gila monster gave the weight-loss revolution its bite
It’s currently estimated that over one-half of the adult US population is either overweight or obese. Being overweight means having a Body Mass Index (BMI) between 25 and 30. Obese means a BMI higher than 30. This statistic shouldn’t be taken to indicate neglect by the healthcare, research, or pharmaceutical industry. In reality, enormous attention […]
Buy Compounded Tirzepatide for Less at IsraelPharm
A crisis struck in 2023 and persisted well into the first few months of 2024. Patients relying on vital medications for diabetes faced a frightening reality: pharmacies, including ours, had to turn away their orders due to shortages. Earlier this year, we published an article detailing the causes of the shortages, titled “Why is it […]
What You Need to Know About Wegovy for Weight Loss
Wegovy, the latest form of semaglutide GLP-1 weight-loss medication, has received a flood of media and public attention thanks to the effectiveness of weight management with Wegovy, which promotes rapid and sustainable weight and waistline reductions. Since we added it to our inventory, we have received a lot of positive feedback from our customers, many of which […]
Medicare now approves weight-loss drugs for people with heart problems
There has been much attention in the media to an announcement from Medicare in mid-March 2024. In essence, it said that it has now agreed to start paying for one of the leading weight-loss drugs for people with heart problems when it is prescribed to treat overweight or obese patients if they are at risk […]
Why it’s so hard to get your weight-loss drugs
On February 2nd, 2024, the venerable New York Times published an article titled “Six Reasons Why It’s So Hard to Get Your Weight-Loss Drugs”. There were few surprises for us in what the NYT wrote because we have been hearing many of the same complaints from new customers who have been struggling to fill their […]
Food Fight: Can Legislation Tackle Obesity?
At the end of October 2023, Governor Gavin Newsom of California signed a trailblazing law set to take effect in 2027. The new law is aimed at forcing food producers to incorporate new levels of safety into their recipes for their products manufactured in the state and sold in California and elsewhere around the country. […]
What’s the difference between Ozempic and Mounjaro?
Ozempic / Wegovy and Mounjaro / Zepbound (and their base components semaglutide and tirzepatide) are currently the “hottest” medications on the market. You don’t have to be a doctor or pharmacist to get to this conclusion; the stock market tells the story. Sales of Ozempic / Wegovy (based on semaglutide) from Novo Nordisk and Mounjaro / […]
Mounjaro is hot news, for good reason
I recently conducted a very informal survey with our staff here at IsraelPharm and asked them a simple question: what healthcare subject are our customers most interested in? 8 out of 10 responded quickly and unequivocally: losing weight, and the medications that can help. What was once a peripheral sideshow of healthcare has become one […]
Expert opinion: Considering Ozempic for weight loss isn’t reckless
In my role as the senior pharmacist here at IsraelPharm, I ensure that we always provide information and respond to questions with evidence-based answers, backed by personal experience and knowledge. Unfortunately, when the internet (namely social media) is our main source of input, we are often confronted with opinions and feedback that contradict medical facts. […]
If it brings such great benefits, why do people stop taking Ozempic?
A natural question has arisen. “If they have such great benefits and are so popular, why do people stop taking Ozempic, Mounjaro and Wegovy?” Ozempic and Mounjaro are considered “wonder drugs” out of all the treatments for type 2 diabetes, which have brought significant benefits to millions of people worldwide who develop type 2 diabetes and caused […]
